Navigation Links
OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
Date:2/6/2013

SAN DIEGO, Feb. 6, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon , President and CEO, will present at the 15th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City, on Tuesday, February 12th at 3:00PM Eastern Time.

(Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)

ABOUT THE BIO CEO & INVESTOR CONFERENCE
The 15th Annual BIO CEO & Investor Conference is the largest independent investor conference focused on publicly-traded biotechnology companies.  This year's conference will feature corporate presentations from more than 150 leading biotechnology and pharmaceutical companies, five Fireside Chats with industry leaders, three Therapeutic Workshops and five Business Roundtables all drawing from seasoned industry executives and analysts. The conference is designed to foster an informative dialogue between institutional investors and senior biotechnology executives about emerging and current investment opportunities. To find out more information on the event, visit http://www.bio.org/events/conferences/bio-ceo-investor-conference

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
2. OncoSec Medical Announces $7.2 Million Public Offering
3. OncoSec Medical to Present Data at DNA Vaccines 2012 Conference
4. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
5. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
6. OncoSec to Present at Upcoming Healthcare and Investor Conferences
7. OncoSec Granted New Patent from China
8. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
9. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
10. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) ... Technology, Imaging and by Application - Forecast to 2020" report ... expected to reach $13.1 Billion in 2020 from an estimated $7.1 ... The market is dominated by North America , ... , and Rest of the World (RoW). The cancer diagnostics market ...
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board of ... announced that Tamas Feitel has joined the ... Numotion after a highly successful 18 year career at ... driving strategy, profitability, and productivity to result in significant ... position was Chief Financial Officer for GE Healthcare Global ...
(Date:7/2/2015)... Mass. , and DURHAM, N.C. ... , Inc. today announced its acquisition of assets related ... (NYSE: PFE ) that had previously been obtained ... XRPro Sciences also acquired all of Pfizer,s rights to ... the Icagen brand and will provide comprehensive services for ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... is the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was ... , The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite 200, ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ... her introduction of the Stop Overdose Stat (S.O.S.) Act of 2015 on June ... (D-R.I.), this Act seeks to decrease drug overdose – especially of heroin and ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations will ... Amica Insurance is sharing some tips to promote the proper use of ... go to the emergency room daily with fireworks-related injuries in the month surrounding the ...
(Date:7/2/2015)... ... ... Achebe realized that the gift of poetry was fully in him, as beautiful phrases riddled ... three years later he was publishing an entire book of poetry. He knew there was ... always believed that the best way to lift yourself up, is in the effort of ...
Breaking Medicine News(10 mins):Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2
... --- "I don,t remember how I got home from the ... one hard-partying college student from another. New research ... report at least one alcohol-induced memory blackout -- a period ... binge. Despite being fully conscious during such blackouts, students could ...
... , MONDAY, July 11 (HealthDay News) -- So-called hypoallergenic dogs ... dogs, a new study says. It,s widely believed that ... fur, making them a healthier choice for people with allergies. ... no scientific evidence that hypoallergenic dogs produce fewer allergens. ...
... patients are tested and treated for osteoporosis when fracture ... disease, a new study has found. Those patients ... mineral density (BMD) testing or prescription drug treatment as ... patients elsewhere. Researchers at St. Michael,s Hospital led ...
... News) -- Although your risk of being struck by ... still smaller by taking some basic precautions. "Lightning ... weather hazards," said Dr. Sandra Schneider, president of the ... news release. "A person,s risk for lightning injury is ...
... have discovered that obese adults undergoing surgery are ... respiratory distress syndrome (ARDS), and that when they ... outcomes. The researchers say they have several theories ... with RI/ARDS, and pinpointing the protective mechanism could ...
... , SATURDAY, July 9 (HealthDay News) -- Too few ... water parks, a new survey suggests. Each year, more than ... up at water parks. Having parents and children shower before they ... to reduce the risk of infection, but there seems to be ...
Cached Medicine News:Health News:Drinking until you forget leads to injuries for college kids 2Health News:The Hype on Hypoallergenic Dogs Is Just That, Study Warns 2Health News:New study highlights what works in osteoporosis treatment 2Health News:Risk of Lightning Strikes Rises in Summer 2Health News:Obese patients less likely to develop and die from respiratory distress syndromes after surgery 2Health News:Obese patients less likely to develop and die from respiratory distress syndromes after surgery 3Health News:Parents Can Help Stop Spread of Water Park Illnesses 2
... multipurpose agarose, has been developed for analytical ... separation of high molecular weight DNA [pulsed-field ... high gel strength agarose ( 1800 g/cm2, ... use of low concentrations of agarose in ...
Inquire...
Inquire...
... UltraClean MS-8 Agarose is an agarose for ... fragments and PCR products. Its main features are:, ... with low base pairs. , Improved clarity of ... competitive products because of a stronger gel structure ...
Medicine Products: